COMMUNIQUÉS West-GlobeNewswire

-
Epizyme to Present at the Jefferies 2017 London Healthcare Conference
09/11/2017 -
INC Research/inVentiv Health Reports Third Quarter 2017 Results
09/11/2017 -
Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference
09/11/2017 -
iSalus Healthcare Opens New Office in Downtown Indianapolis
09/11/2017 -
Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI)
09/11/2017 -
RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2017 Guidance Levels
09/11/2017 -
Crown Bioscience Inc. Announcing the 2017 Board of Directors Election Results
09/11/2017 -
Ossur Hf : Management Changes
09/11/2017 -
Share Capital and Votes
09/11/2017 -
Bavarian Nordic Announces Initiation of Phase 2 Booster Study of its Universal RSV Vaccine
09/11/2017 -
VALNEVA publie une très forte performance opérationnelle sur les neufs premiers mois de l'exercice 2017
09/11/2017 -
VALNEVA Reports Strong Operational Performance for the First Nine Months of 2017
09/11/2017 -
ABLYNX TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN LONDON AND PARIS
09/11/2017 -
Apellis Pharmaceuticals Announces Pricing of Initial Public Offering
09/11/2017 -
Sarepta Therapeutics Prices $475 Million of Convertible Senior Notes Due 2024
09/11/2017 -
Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering
09/11/2017 -
New Eftilagimod Alpha (LAG-3Ig or IMP321) Data for Presentation at the Society for Immunotherapy of Cancer (SITC) 2017 Annual Meeting
08/11/2017 -
Cocrystal Pharma Announces Filing 2017 Third Quarter Financial Statements and Provides Company Update
08/11/2017 -
Atrion Corporation Declares Quarterly Cash Dividend
08/11/2017
Pages